Ascendis Pharma A/S Adjustments For Decrease Increase In Other Operating Receivables
Ascendis Pharma A/S (ASND) reported Adjustments For Decrease Increase In Other Operating Receivables of EUR 19.00 thousand for the 9-month period ending 2019-09-30, per its 6-K filed 2019-11-18.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2019-11-18
- Ascendis Pharma A/S adjustments for decrease increase in other operating receivables for the quarter ending 2019-09-30 was -305.00K EUR.
- Ascendis Pharma A/S adjustments for decrease increase in other operating receivables for the quarter ending 2019-06-30 was 5.52M EUR.
- Ascendis Pharma A/S adjustments for decrease increase in other operating receivables for the quarter ending 2019-03-31 was -5.20M EUR, a 1942.20% decline year-over-year.
- Ascendis Pharma A/S adjustments for decrease increase in other operating receivables for the quarter ending 2018-12-31 was 975.00K EUR.
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 3 month | Adjustments For Decrease Increase In Other Operating Receivables 6 month | Adjustments For Decrease Increase In Other Operating Receivables 9 month | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|---|---|---|
| 2019-09-30 | -305.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 5.21M EUR derived: sum of 2 quarters · filed 2019-11-18 | 19.00K EUR 6-K · filed 2019-11-18 | 994.00K EUR derived: sum of 4 quarters · filed 2019-11-18 |
| 2019-06-30 | 5.52M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 324.00K EUR 6-K · filed 2019-08-28 | 1.30M EUR derived: sum of 3 quarters · filed 2019-08-28 | 375.00K EUR derived: sum of 4 quarters · filed 2019-11-18 |
| 2019-03-31 | -5.20M EUR 6-K · filed 2019-05-30 | -4.22M EUR derived: sum of 2 quarters · filed 2019-05-30 | -5.14M EUR derived: sum of 3 quarters · filed 2019-11-18 | -5.84M EUR derived: sum of 4 quarters · filed 2019-11-18 |
| 2018-12-31 | 975.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-04-03 | 51.00K EUR derived: sum of 2 quarters · filed 2019-11-18 | -647.00K EUR derived: sum of 3 quarters · filed 2019-11-18 | -365.00K EUR 20-F · filed 2019-04-03 |
| 2018-09-30 | -924.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | -1.62M EUR derived: sum of 2 quarters · filed 2019-11-18 | -1.34M EUR 6-K · filed 2019-11-18 | -2.14M EUR derived: sum of 4 quarters · filed 2019-11-18 |
| 2018-06-30 | -698.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | -416.00K EUR 6-K · filed 2019-08-28 | -1.22M EUR derived: sum of 3 quarters · filed 2019-08-28 | -637.00K EUR derived: sum of 4 quarters · filed 2019-08-28 |
| 2018-03-31 | 282.00K EUR 6-K · filed 2019-05-30 | -520.00K EUR derived: sum of 2 quarters · filed 2019-05-30 | 61.00K EUR derived: sum of 3 quarters · filed 2019-05-30 | 793.00K EUR derived: sum of 4 quarters · filed 2019-05-30 |
| 2017-12-31 | -802.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-04-03 | -221.00K EUR derived: sum of 2 quarters · filed 2019-04-03 | 511.00K EUR derived: sum of 3 quarters · filed 2019-04-03 | -770.00K EUR 20-F · filed 2019-04-03 |
| 2017-09-30 | 581.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | 1.31M EUR derived: sum of 2 quarters · filed 2018-11-28 | 32.00K EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 732.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | -549.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | -1.28M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | -302.00K EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | -128.00K EUR 20-F · filed 2018-03-28 |